07.04.2014 Views

Acute Flaccid Paralysis Accompanying West Nile Meningitis Ahmed ...

Acute Flaccid Paralysis Accompanying West Nile Meningitis Ahmed ...

Acute Flaccid Paralysis Accompanying West Nile Meningitis Ahmed ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Use of Opioids in Management of Chronic Pain in Non-Cancer Patients<br />

Schug, M, D.O., Hamad, K, M.D., Vanumu, V, M.D.<br />

Saint Elizabeth Medical Center, Family Medicine Residency, Utica, NY<br />

Introduction: Past research has shown that the long-term use of opioids within the structure<br />

of strict treatment guidelines, is successful in reducing pain and improving functionality of<br />

patients. Establishing the goals of treatment is essential to successful pain management with<br />

opioids. Periodic review of a patient’s care is essential, using appropriate medication<br />

adjustments with assessment of activity level and pain levels. Goals of treatment center on<br />

improved pain control with improved functionality and quality of life. These goals will ideally be<br />

mutually arrived at, by patient and provider, with periodic visits using opiate treatment<br />

guidelines.<br />

Our research involves the implementation of such guidelines at the Sister Rose Vincent<br />

Family Medicine Center at the St. Elizabeth Medical Center in Utica, NY; these aim to direct<br />

opiate prescription in treatment of chronic pain to both reduce pain and to increase functional<br />

status and quality of life. We aim to demonstrate that adherence to opiate treatment guidelines,<br />

even if and when it calls for reduction in dosages of opiates prescribed over a three month<br />

period, will produce either no change or a possible improvement in patient functionality, without<br />

a corresponding increase in reported pain levels by patients. At the same time, we expect that<br />

at the time of initial implementation of guidelines, patient’s satisfaction may decrease or levels<br />

of reported pain may increase, due to the patient’s initial response to the change in their<br />

treatment.<br />

Methods: Subjects have included pain patients from the Sister Rose Vincent Family Medicine<br />

Center over the age of 18, both male and female. The patient pool included those with chronic,<br />

noncancerous pain (such as chronic neck pain, chronic back pain and fibromyalgia) who had<br />

been prescribed opiate pain medications for six months prior to the study; those from this pool<br />

who volunteered to participate in the study were included. While our initial aim was to have a<br />

sample size of100 patients, we have found significant resistance to participation from many<br />

patients. After a research participation agreement was introduced and accepted, participating<br />

subjects were administered a 4-question questionnaire, asking their assessment of pain since<br />

last visit, current pain level, perception of functional status in relation to pain since last visit and<br />

current functional status; this assessment took place monthly. Additionally, the type and dose<br />

of opioid medication used, date of starting medication, date of exam, age, sex, and any<br />

adverse events were recorded. Three months after initial data was collected, new pain<br />

management guidelines are being implemented for the subjects. These guidelines include<br />

instructions on approaches to stratifying patients in terms of opiate risk potential, and adjusting<br />

the type and dosage of opiate medication accordingly. Subjects then are assessed monthly<br />

with the same questionnaire as they did for their earlier visits to the clinic once these guidelines<br />

are in place.<br />

The level of pain, functional status, and medication dosage will be compared before and<br />

after applying the guidelines. Improvement will be determined to have occurred: 1) if pain and<br />

functional status decrease and increase, respectively, with correlating dosage staying the same<br />

pre and post guideline implantation, or 2) if pain and functional status either remain the same<br />

or improve when opiate dosage decreased after the guideline implementation.<br />

Trend analysis and t-tests will be used for analysis of collected data.<br />

Results: Currently data is being collected as the study will run until April 15, 2013<br />

Conclusions: Not available at this time

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!